FDA okays expanded offering of Powerlink stent graft products
Endologix Inc, a medical device maker, said it has received approval from the US regulatory authority to market an expanded offering of its Powerlink stent graft products. Powerlink, which is an already approved endovascular stent graft, is used in the treatment of abdominal aortic aneurysm. In abdominal aortic aneurysm, the aortic wall weakens, creating a “ballooning” of the blood vessel.
-
FDA approves PMA supplement for Endologix’s Powerlink XL® System
FDA nod to Bard’s Flair™ Endovascular Stent Graft
FDA nod to Endologix’s IntuiTrak™ Delivery System
Medtronic Debuts Medical Device in U.S. Designed to Improve Treatment of Aortic Aneurysms
FDA Approves Expansion of Endologix’s Main Product Line
